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Lifestyle index for mortality 
prediction using multiple ageing 
cohorts in the USA, UK and Europe
Jing Liao1,2, Graciela Muniz-Terrera3, Shaun Scholes4, Yuantao Hao1,2 & Yu-ming Chen  1
Current mortality prediction indexes are mainly based on functional morbidity and comorbidity, with 
limited information for risk prevention. This study aimed to develop and validate a modifiable lifestyle-
based mortality predication index for older adults. Data from 51,688 participants (56% women) aged 
≥50 years in 2002 Health and Retirement Study, 2002 English Longitudinal Study of Ageing and 2004 
Survey of Health Ageing and Retirement in Europe were used to estimate coefficients of the index 
with cohort-stratified Cox regression. Models were validated across studies and compared to the 
Lee index (having comorbid and morbidity predictors). Over an average of 11-year follow-up, 10,240 
participants died. The lifestyle index includes smoking, drinking, exercising, sleep quality, BMI, sex 
and age; showing adequate model performance in internal validation (C-statistic 0.79; D-statistic 1.94; 
calibration slope 1.13) and in all combinations of internal-external cross-validation. It outperformed 
Lee index (e.g. differences in C-statistic = 0.01, D-statistic = 0.17, P < 0.001) consistently across health 
status. The lifestyle index stratified participants into varying mortality risk groups, with those in the 
top quintile having 13.5% excess absolute mortality risk over 10 years than those in the bottom 50th 
centile. Our lifestyle index with easy-assessable behavioural factors and improved generalizability may 
maximize its usability for personalized risk management.
Lifestyle factors contribute substantially to chronic diseases and mortality even in old age1, with unhealthy behav-
iours tending to occur together and exert a synergistic effect on health2. To investigate the combined effects of 
multiple behavioural factors on health, most epidemiological studies have generated a lifestyle index by adding 
the number of dichotomous risky or non-risky behavioural indicators1,3,4. This approach is straightforward but 
may arbitrarily assign behaviours into the ‘risky’ category and overlook the dependence between behaviours and 
their relative importance to health3.
On the other hand, risk indices derived from prediction models can generate more objective estimations of 
multiple risk factors on health and further predict the absolute risk of an event for individuals with certain risk 
profiles over a specific time period5. So far, however, few mortality prediction models for community-dwelling 
older adults have been constructed. Existing indices focus mainly on functional morbidity measures6,7 or involve 
11–12 risk factors8,9 including demographic characteristics and self-reported comorbid and functional conditions 
to predict up to 10-year mortality10,11. Their predictive value notwithstanding, these indices cannot provide infor-
mation for risk intervention. The prevention of disease development and functional decline is better achieved 
through upstream modifiable lifestyle factors12. Additionally, most indices were derived in a single sample of 
North American older adults and lack external validation13.
Therefore, this study aimed to develop and validate a mortality prediction index based on modifiable lifestyle 
factors using three population-representative ageing cohorts in the US, UK and Europe. These internationally 
collaborative epidemiologic cohorts enable detailed investigation on the predictive performance of our lifestyle 
index, while taking between-cohort heterogeneity into account14,15. A lifestyle index for mortality that performs 
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well across cohorts enhances its credibility and generalizability, and may then be utilized for risk prevention 
through behaviour changes.
Results
Characteristics of the Study Sample. Among the 51,688 participants, 10,240 deaths (19.8%) occurred 
over an average of 11 years of follow-up (dates varied, HRS 13 years, ELSA 11 years and SHARE 9.5 years). The 
distribution of baseline lifestyle measures varied between cohorts (Supplementary Table S1) that higher per-
centages of SHARE participants were never smokers, heavy drinkers and were physically active; whereas ELSA 
participants were moderate drinkers, slept restlessly and were overweight or obese.
Lifestyle-Based Risk Prediction Model for Mortality. The cohort-stratified Cox regression of multiple 
lifestyle factors for mortality indicated that smoking, physically inactivity and underweight were associated with 
increased mortality, while restless sleep was an independent risk factor for men only (Table 1). Regression esti-
mates of lifestyle factors for mortality were similar across cohorts (results not shown), except that heavy drinking 
was only a risk factor in HRS (p for cohort interaction <0.01). Conditional on risk predictors included, the three 
cohorts showed similar baseline distributions which can be jointly modelled as a restricted regression spline with 
1 internal knot (Supplementary Fig. S1).
Model Validation. The lifestyle prediction model showed good discrimination (Table 2). The pooled 
C-statistic and D-statistic estimates of internal validation were 0.79 and 1.94 with similar performance in each 
round of IECV (i.e., C-statistic range 0.77–0.81, D-statistic range 1.85–2.06), indicating good discrimination 
consistently across cohorts. Regarding calibration, the pooled calibration slope 1.13 was slightly larger than 1.0, 
suggesting that the predicted mortality risk may be lower than the observed risk. Comparable findings were 
drawn from IECV analysis of the calibration slope and calibration plots (Supplementary Fig. S2), showing that 
the under-prediction of mortality risk was most evident in ELSA. Our lifestyle-based model outperformed Lee’s 
model8,10 that includes comorbid conditions (i.e., diabetes mellitus, cancer, lung disease and heart failure) and 
functional variables (i.e., bathing, managing finances, walking several blocks and pushing/pulling heavy objects), 
Predictors Mean or % βa [95%CI]
Ln-age 4.2 6.343 [5.737,6.949]
Gender
Male 44.4 Ref.
Female 55.6 −0.476 [−0.574,−0.377]
 Female*Lnage 0.589 [0.092,1.086]
Smoking status
Never smoker 51.0 Ref.
Ex-smoker 32.4 0.330 [0.262,0.399]
Current smoker 16.6 0.771 [0.672,0.871]
Drinking status
Nondrinker 38.3 0.345 [0.270,0.421]
Former drinker 10.8 0.131 [0.027,0.234]
Moderate drinker 37.9 Ref.
Heavy drinker 13.0 0.106 [−0.025,0.237]
Physical activity level
High 40.1 −0.417 [−0.496,−0.338]
Medium 44.5 Ref.
Low 15.4 0.770 [0.683,0.856]
Sleep restless
No 68.6 Ref.
Yes 31.4 0.211 [0.118,0.304]
 Female*Yes −0.260 [−0.396,−0.125]
BMI
≤20 4.3 0.442 [0.308,0.577]
>20–25 34.7 0.160 [0.091,0.229]
>25–30 41.1 Ref.
>30 19.9 0.115 [0.036,0.195]
Table 1. Baseline lifestyle measures and associations with mortality cases in 2013–2014 (N = 51,688). Data: 
Health and Retirement Study, English Longitudinal Study of Ageing and Survey of Health, Ageing and 
Retirement in Europe. BMI, Body mass index; CI, confidence interval; Ref., reference group. aBeta coefficients 
were derived from Cox regression models stratified by cohort. Statistically-significant sex interaction terms 
were in italic with * signs. Age was naturally logarithmically transformed to improve the model fit and was 
centred at 66 years.
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showing consistently improved discrimination, e.g. the difference between two indexes was 0.01 for C-statistic 
(P < 0.001) and 0.17 for D-statistic (P < 0.001), and calibration (1.13 vs 0.80) in the total subsample, as well as 
among participants with and without clinical conditions (Table 2). This subgroup analysis further indicated that 
our lifestyle index seemed to perform better in healthy participants than those with clinical conditions.
Lifestyle Index for Mortality. Table 3 shows the lifestyle-based index that consists of points for each risk 
predictor, total points and corresponding absolute risk of 10-year mortality. In our study sample, the lifestyle 
index ranged from −2 to 15 (mean [SD], 4.3[3.0]), which effectively stratified individuals into groups with var-
ying mortality risks. Kaplan-Meier survival curves for three prognostic groups at 50th and 80th centiles of the 
lifestyle index (i.e., 4 and 7 points) showed reasonably good agreement with the estimated survival curves, and 
the separation between groups was well maintained across the individual cohorts (Fig. 1).
Discussion
We developed and validated a lifestyle-based risk index for mortality of older adults aged 50 years and above, 
using three comparable ageing cohorts in the US (HRS), UK (ELSA) and Europe (SHARE). The index includes 
modifiable smoking, drinking, exercising, sleeping quality and BMI, besides age and sex. It validated rather well 
in terms of discrimination, but less well regarding calibration to the extent that the mortality risks may be under-
estimated in high-risk individuals. Nonetheless, our lifestyle index effectively stratified older adults into varying 
mortality risk groups and demonstrated equivalently adequate performance in each round of internal-external 
cross-validation. It is thus reasonable to present a single lifestyle risk index with improved generalizability based 
on data from all three cohorts.
Our lifestyle index identifies high risk older adults via the most common and easily-assessable lifestyle factors, 
and showed better performance than indices with comorbidities and functional status8,10 regardless of partici-
pants’ health status. The development of clinical conditions may be on the pathway of lifestyle factors to mortality, 
as such weakening the predictive value of lifestyle risk factors12. Prediction models based on upstream lifestyle 
risk factors are of the most relevance for disease prevention, and provide useful information for personalized 
intervention targeted on modifiable unhealthy behaviours. Our lifestyle index with adequate performance in the 
absence of clinical risk factors enables itself to be easily implemented into different care settings.
Moreover, our lifestyle index for mortality exceeds previous indices by demonstrating its generalizability 
across three independent ageing cohorts. Current mortality prediction indices for older adults were predom-
inately developed in a single homogenous sample of the American population6–9, which cannot be directly 
transported to other populations. Our study instead derived the lifestyle index from diverse populations 
Models N C-statistic β [95%CI] D-statistic β [95%CI] Calibration slope β [95%CI]
Internal validationa 51,688 0.792 [0.787,0.796] 1.937 [1.901,1.972] 1.125 [1.087,1.162]
Internal-external cross-validationb
HRS & ELSA (D) 25,390 0.788 [0.783,0.793] 1.979 [1.912,2.048] 0.964 [0.936,0.992]
SHARE (V) 26,298 0.805 [0.797,0.813] 2.058 [1.951,2.165] 0.965 [0.919,1.010]
HRS & SHARE (D) 41,177 0.798 [0.793,0.803] 2.068 [2.010,2.126] 1.073 [1.035,1.111]
ELSA (V) 10,511 0.803 [0.794,0.812] 1.875 [1.791,1.958] 1.045 [0.985,1.105]
ELSA & SHARE (D) 36,809 0.804 [0.798,0.811] 2.064 [1.963,2.165] 1.030 [0.990,1.071]
HRS (V) 14,879 0.773 [0.767,0.779] 1.846 [1.779,1.912] 0.996 [0.958,1.033]
Lifestyle index vs. Lee indexc
Lifestyle index
Total 29,105 0.764 [0.758,0.769] 1.738 [1.676,1.800] 1.130 [1.086,1.174]
With clinical 
conditions 11,716 0.729 [0.721,0.736] 1.445 [1.365,1.525] 0.972 [0.917,1.026]
Without clinical 
conditions 17,389 0.771 [0.763,0.780] 1.877 [1.781,1.972] 1.183 [1.115,1.252]
Lee index
Total 29,105 0.751 [0.745,0.756] 1.564 [1.492,1.636] 0.798 [0.766,0.830]
With clinical 
conditions 11,716 0.712 [0.704,0.719] 1.276 [1.188,1.364] 0.751 [0.706,0.795]
Without clinical 
conditions 17,389 0.744 [0.736,0.753] 1.695 [1.598,1.791] 1.047 [0.984,1.110]
Table 2. Lifestyle-based predication model performance. Data: Health and Retirement Study, English 
Longitudinal Study of Ageing and Survey of Health, Ageing and Retirement in Europe. HRS, Health and 
Retirement Study; ELSA, English Longitudinal Study of Ageing; SHARE, Survey of Health, Ageing and 
Retirement in Europe; CI, confidence interval. aInternal validation was assessed using a weighted meta-analysis 
that the pooled estimates were the weighted averages of study-specific estimates. bInternal-external cross-
validation interactively withheld one of the cohort (V: validation cohort) to externally validate the prediction 
model derived from the other remaining cohorts (D: development cohorts). cComparison was conducted in a 
subsample that had all measures of both lifestyle index and Lee index (Lee et al., 2006.), and separately for these 
with/without clinical conditions (i.e., diabetes mellitus, cancer, lung disease and heart failure at baseline).
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representing several countries, carefully accounting for the between-cohort heterogeneity16,17. We fitted one-stage 
stratified models that generate similar risk scores over multiple cohorts as a two-stage fixed- or random-effects 
meta-analysis, and has the advantage of simplicity14,15. We found comparable proportional associations of life-
style predictors on mortality across the selected cohorts, except for a weak heterogeneity in the heavy drinking 
effect between HRS and SHARE male participants only. We also found similar baseline distributions among three 
cohorts conditional on lifestyle factors included, which validated the estimation of a pooled baseline function18. 
Our findings were in line with results from other multi-country and cohort pooling studies19,20, which may imply 
similar underlying biology of lifestyle factors across these demographics.
External validation is essential for a prognostic model’s clinical and public health applications13,21. Only one 
of the current mortality indices for older adults was tested in an independent sample of new respondents to the 
original survey11, but under the identical survey setting the variation between the development and validation 
datasets was minor. We employed the IECV approach as suggested by recent literature reviews14,16 to evaluate the 
lifestyle index’s performance regarding both discrimination and calibration. For all combinations of the IECV, 
good discrimination was indicated by both C-statistic and D-statistic concordantly, as well as fairly adequate 
calibration in the face of some evidence of underprediction in the high-risk groups (<20% of the study sample). 
Given discrimination is a more relevant indicator for risk stratification than calibration21, our lifestyle-based 
index performed consistently well across all cohorts.
Our study developed a robust lifestyle-based prognostic index that validated across three large 
population-representative ageing cohorts. This index has the advantages of simplicity, increased precision and 
generalizability, which enable better transportability than prognostic models derived from a single dataset. 
However, several limitations should be noted. First, despite efforts taken to harmonizing these datasets, our study 
may still be affected by variations in lifestyle measures. Thus, the apparent differences in baseline lifestyle distri-
bution between cohorts may reflect a combination of variations in survey questions, social- and cultural-biases 
in self-reported measures, and true between-cohort differences. Also, confined to lifestyle measures available in 
these surveys, our index was unable to include all lifestyle risk factors for mortality. This parsimonious index yet 
covers these common and critical lifestyle factors related to mortality1 and provides better stability and transport-
ability across multiple studies than comprehensive indices13,18. Second, we focused on lifestyle measures 10 years 
before death events to minimize the reversed influence from poor health to behaviours. However, this one-time 
assessment cannot take into account changes in lifestyle patterns over time, and could lead to an underestima-
tion of the average cumulative exposure to these factors on mortality22,23. Although within-person change in 
health-related behaviours may not be substantial in older adulthood22, incorporating behavioural patterns of 
multiple waves would nevertheless improve the precision of the current analysis. Third, SHARE covers most of 
the European Union countries with inevitably different lifestyle characteristics and health status. Nevertheless, we 
did not find statistically-significant differences in lifestyle-mortality associations among these countries (result 
not shown), and hence used them collectively as representing the average level of Europe. Fourth, we adopted the 
IECV approach to maximize the number of datasets available for model development as well as for external vali-
dation, but we note that this approach is only partially external18 and may be limited given the number of selected 
cohorts in our study is small16,17. Last, as the present study was mainly focused on North American and European 
Caucasian older adults, its generalizability to other non-white populations requires further external validation.
In conclusion, this study developed a lifestyle-based index to predict 10-year mortality risk among 
community-dwelling older adults of the US, UK and Europe. In terms of validation, the lifestyle index showed 
consistently adequate discrimination and calibration across these geographically and socio-demographically 
diverse cohorts. Our lifestyle index demonstrated simplicity, credibility and generalizability and may serve as a 
practical tool for personalized risk assessment and management in older adults.
Points −1 0 1 2 3 4 5 6 7 8
Age 50–54 55–59 60–64 65–69 70–74 75–79 80–84 ≥85
Sex Female Male
Smoking status Never Past Now
Drinking status Former/Moderate None/Heavy
Physical activity level High Medium Low
Restless sleep No Yes (Male)
BMI (weight/height2) >20 ≤20
Total Points (TP) −2 −1 0 1 2 3 4 5 6 7 8 9 10 11+
10-y mortality risk% 0.4 0.6 0.9 1.3 2.1 3.1 4.8 7.3 10.9 16.3 23.9 34.2 47.5 62.8
Risk groups  50th centile  50th-<80th centile  ≥80th centile 
Table 3. Lifestyle-based index for10-year mortality risk in older adults. Data: Health and Retirement Study, 
English Longitudinal Study of Ageing and Survey of Health, Ageing and Retirement in Europea. aA summary 
risk score for each participant was calculated as the total points for all risk predictors present. For example, a 
participant aged 60–64 (score 3), male (0), being a current smoker (2), low in physical activity (2), restless sleep 
(1), and BMI = 20 (1) has total points of 9, and associated with a 34.2% absolute mortality risk in 10 years.
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Methods
Study Sample. Data from three comparable national panel surveys were used, namely the Health and 
Retirement Study (HRS)24, the English Longitudinal Study of Ageing (ELSA)25 and the Survey of Health Ageing 
and Retirement in Europe (SHARE)26. All the procedures were conducted in accordance with the approved guide-
lines and informed consent was obtained from all participants of respective cohort. HRS was approved by the 
University of Michigan Health Science/Behavioural Sciences Institutional Review Board, ELSA was approved by 
Figure 1. Kaplan-Meier survival curves (solid lines) and estimated average survival curves (dash lines) for 
three prognostic groups in the pooled data and in each cohort. The groups in each plot are defined by the 
cut-points at 50th and 80th centiles of the lifestyle index. HRS: Health and Retirement Study; ELSA, English 
Longitudinal Study of Ageing; SHARE: Survey of Health, Ageing and Retirement in Europe.
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the London Multicentre Research Ethics Committee, and SHARE was approved by the Ethics Committee of the 
University of Mannheim and the Ethics Council of the Max Planck Society.
The present study included participants who were 50 years and older in the 2002 HRS, the 2002 ELSA, and the 
2004 SHARE, and had complete lifestyle measures and linkage to death records up to 2013–2014. This resulted 
in an analytical sample of 51,688 (56% women). Participants with missing measures (11% HRS, 8% ELSA, 2% 
SHARE) tended to be older, male and less educated than the study sample.
Mortality Ascertainment. All surveys trace participants’ mortality status and conduct exit interviews with 
the decedent’s spouse, child or other informant. We used mortality data updated to the end of 2013 (2014 for 
HRS). HRS and ELSA also monitor vital status by locating respondents with the National Death Index or the 
National Health Service’s Central Registry.
Risk Predictors. Besides age and sex, we included well-established lifestyle factors of mortality in accordance 
with the literature1,2. Full details on the harmonization of the baseline measures across the studies is provided 
in supplementary text (Supplementary Text S1). Smoking status was categorized as non-smoker (reference), 
ex-smoker or current smoker. Drinking status was coded as non-drinker (zero-alcohol intake), former drinker, 
moderate (≤two drinks/day, reference) and heavy drinker (>two drinks/day). Physical activity level was defined 
as high (vigorous exercise at least once per week), medium (moderate exercise at least once per week, reference) 
and low (hardly ever/never moderate-vigorous exercise). Sleep quality was measured by ‘whether sleep was rest-
less’ (No = 0, Yes = 1). Body mass index (BMI, kg/m2) was grouped into four classes ≤20, >20–25, >25–30 (ref-
erence) and >30 kg/m2.
Statistical analysis. We used Cox regression stratified by cohort to estimate coefficients of the lifestyle 
model. Risk predictors were modifiable health-related behaviours namely smoking, drinking, physical activ-
ity, sleep quality and BMI, as well as sex and age (a natural log transformation was used to improve model 
fit). Backward selection was used, and variables that were independent predictors of mortality in the multi-
variable models (p < 0.05) were included in the final prediction model. We tested sex variations in all asso-
ciations by using interaction terms, and examined the between-cohort heterogeneity in predictor-mortality 
associations and in baseline distribution functions; whereby a pooled baseline survival function was esti-
mated via flexible parametric proportional hazards models18 using a restricted natural cubic spline function 
of log time.
We validated the lifestyle prediction model by assessing discrimination and calibration. Discrimination 
(i.e. the ability of a predictive model to separate those who died from those who did not) was assessed by 
Harrell’s Concordance (C-statistic)27 and Royston and Sauerbrei’s separation Discrimination (D-statistic)28. 
Larger values indicate better discrimination. Calibration (which reflects prediction accuracy) was evaluated by 
the calibration slope and calibration plot. A calibration slope closes to 1.0 suggests good calibration, while the 
calibration curve going through the origin with a 45-degree slope indicates perfect prediction. We validated 
the prediction model in three ways. First, we conducted internal validation across cohorts using a weighted 
meta-analysis, where estimates from individual cohorts were combined to obtain the weighted average15. 
Second, we adopted the internal-external cross-validation (IECV) approach18 that interactively withheld data 
from one of the cohort to externally validate the prediction model derived from the two remaining cohorts. 
Third, we compared the performance of our lifestyle model with the 12-item prognostic index developed by 
Lee and colleagues8,10, in the presence and absence of clinical conditions (i.e., diabetes mellitus, cancer, lung 
disease and heart failure).
The lifestyle prediction model was then translated into a simplified point-based lifestyle index using methods 
reported previously29. Briefly, points were assigned to each risk predictor by dividing the corresponding β coef-
ficient by the β coefficient of a five-year increase in age and rounding to the nearest integer; with positive values 
indicating increased risks and negative values indicating decreased risks. A summary risk score for each participant 
was the total points for all risk predictors present. The 10-year absolute mortality risk associated with point totals 
was calculated using flexible parametric proportional hazards model with the pooled baseline survival function. 
Given no more than 11% participants had missing value, all analyses were conducted among participants with 
complete measures and adjusted by the individual-level weights provided with the data. All analyses were con-
ducted via Stata SE version 14 (StataCorp, College Station, TX).
Data availability. The analysis was based on the RAND HRS, the Harmonized ELSA and Harmonized 
SHARE datasets. These datasets are available from the Gateway to Global Aging Data website: www.g2aging.org.
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